Neuralink Launches First European Brain Chip Trial in UK with Seven Paralyzed Patients

Neuralink, Elon Musk's brain-computer interface company, has begun its first clinical trial in the United Kingdom, recruiting seven patients with severe paralysis to test its fully implantable N1 brain chip. The device allows users to control digital tools using thoughts alone, representing a significant milestone in neurological technology development. This European expansion marks Neuralink's first trials outside the United States and demonstrates growing international adoption of experimental brain-computer interfaces. The trial's success could reshape treatment options for paralysis patients globally and influence regulatory frameworks for neural implants across allied nations.